(Q34574028)

3 August 2017

1 reference

title

Pharmacogenetics: the ethical context (English)

1 reference

3 August 2017

0 references

S M Thomas

1

1 reference

3 August 2017

1 January 2001

1 reference

The Pharmacogenomics Journal

3 August 2017

1 reference

3 August 2017

1

1 reference

3 August 2017

4

1 reference

3 August 2017

239-242

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.tpj.6500052

3 August 2017

0 references

cites work

Pharmacogenetics and the practice of medicine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500052

Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500052

Apolipoprotein E variation at the sequence haplotype level: implications for the origin and maintenance of a major human polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500052

Clinical trials in the genomic era: effects of protective genotypes on sample size and duration of trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500052

Pharmacogenetics and adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500052

Pharmacogenomics: translating functional genomics into rational therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500052

Racial differences in the response to drugs--pointers to genetic differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500052

Ethical and legal implications of pharmacogenomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500052

Racial Profiling in Medical Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500052

Pharmacogenetic applications of the Human Genome project

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500052

inferred from DOI database lookup

7 January 2021

based on heuristic

Apolipoprotein E genotyping for pharmacogenetic purposes in Alzheimer's disease: emerging ethical issues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500052

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.TPJ.6500052

1 reference

PubMed ID

11908766

Dimensions Publication ID

3 August 2017

0 references

1 reference

PubMed ID

11908766